SCHEMBL1064459

SCHEMBL1064459

CCCCOC(=O)NC(Cc1ccco1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.48
CTSS P25774 2/20 0.48
HPGD P15428 2/20 0.46
CYP1A2 P05177 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.45
FOLH1 Q04609 2/20 0.44
POLB P06746 3/20 0.43
USP2 O75604 1/20 0.42
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 2/20 0.42
APEX1 P27695 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
TYR P14679 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3573493 0.87 CTSS (0.52) CTSKCTSSMAPTCYP2C19SMN1; SMN2
SCHEMBL2185240 0.81 ITGB3 (0.58) CTSKCTSSCTSLITGB3ITGA2B
SCHEMBL7758997 0.81 ITGB3 (0.58) CTSKCTSSCTSLITGB3ITGA2B
SCHEMBL844471 0.81 ITGB3 (0.58) CTSKCTSSCTSLITGB3ITGA2B
SCHEMBL9256981 0.80 TYR (0.56) CTSKCTSSMAPTSMN1; SMN2POLB
SCHEMBL7389196 0.80 TYR (0.56) CTSKCTSSMAPTSMN1; SMN2POLB
SCHEMBL1068894 0.79 CTSS (0.73) CTSKCTSSFOLH1CTSLCTSB
SCHEMBL9955720 0.79 CTSS (0.73) CTSKCTSSFOLH1CTSLCTSB
SCHEMBL1068898 0.79 CTSS (0.73) CTSKCTSSFOLH1CTSLCTSB
SCHEMBL2837951 0.78 CTSS (0.50) CTSKCTSSHPGDMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2274297-A1 PYRROLIDINONE GLUCOKINASE ACTIVATORS F. Hoffmann-La Roche AG (CH) 2011-01-19 EP disclosed
EP-1791837-A1 SUBSTITUTED HYDANTOINS FOR THE TREATMENT OF CANCER F. Hoffmann-Roche AG (CH) 2007-06-06 EP disclosed
WO-2006029862-A1 SUBSTITUTED HYDANTOINS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2006-03-23 WO disclosed